Table 2: Main results for experimental studies.

Author, year

Main result

Systematic review conclusion

Body weight

Weight

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral or reduction effect on total body weight.

Santana, et al. (2015) [34]

Total body weight has decreased after GT treatment (p < 0.05)

Lu, et al. (2012) [35]

Total body weight has decreased after GT treatment (p < 0.05)

Shen, et al. (2015) [36]

No significant changes (p > 0.05)

Body Fat Mass

Shen, et al. (2015) [36]

Body fat mass has decreased after GT treatment (p < 0.05)

The intake of GT may suggest a neutral or reduction effect on body fat mass.

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

Body Fat-Free Mass

Shen, et al. (2015) [36]

Body fat-free mass has increased after GT treatment (p < 0.05)

The intake of GT may suggest a elevation effect on body fat-free mass.

Inflammatory profile

TNF

Santana, et al. (2015) [34]

WAT TNF has decreased after GT treatment (p < 0.05)

The intake of GT may suggest a reduction effect on liver TNF and a neutral effect on blood TNF.

Rocha, et al. (2015) [33]

No significant changes in blood TNF (p > 0.05)

IL-6

ROCHA, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral or reduction effect on IL-6.

Lu, et al. (2012) [35]

Serum IL-6 has decreased after GT treatment (p < 0.05)

IL-1β

ROCHA, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral or reduction effect on IL-1β.

Lu, et al. (2012) [35]

Serum IL-1β has decreased after GT treatment (p < 0.05)

Glycemic profile

Glucose

ROCHA, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT may suggest a neutral or elevation effect on serum glucose.

Santana, et al. (2015) [34]

Serum glucose has increased after GT treatment (p < 0.05)

Insulin

Santana, et al. (2015) [34]

Serum insulin has increased after GT treatment (p < 0.05)

The intake of GT may suggest a elevation effect on serum insulin.

Homa-IR

Santana, et al. (2015) [34]

HOMA-IR has increased after GT treatment (p < 0.05)

The intake of GT may suggest a elevation effect on HOMA-IR.

Cardiovascular health

TC

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral effect on TC.

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

TG

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral effect on TG.

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

HDL

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral effect on HDL.

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

LDL

Rocha, et al. (2015) [33]

No significant changes (p > 0.05)

The intake of GT suggests a neutral effect on LDL.

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

FFA

Rocha, et al. (2015) [33]

FFA has decreased after GT treatment (p < 0.05)

The intake of GT suggests a neutral or reduction effect on FFA.

Santana, et al. (2015) [34]

No significant changes (p > 0.05)

GT: Green Tea; WAT: White Adipose Tissue; TNF: Tumor Necrosis Factor; IL-6: Interleukin 6; IL-1β: Interleukin 1 beta; CRP: C-reactive Protein; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; HbA1c: Glycated Hemoglobin; TC: Total Cholesterol; TG: Triglycerides; HDL: High-Density Lipoprotein Cholesterol; LDL: Low-Density Lipoprotein Cholesterol; FFA: Free Fatty Acids